The PennZone

  • Home
  • Non-profit
  • Books
  • Marketing
  • Music
  • Entertainment
  • Health
  • Business
  • Automotive

Gary S. Monroe, C.D. Accelerates Promising New Treatments For Cocaine And Methamphetamine Addicts
The PennZone/10119511

Trending...
  • Timbrana Helps General Contractors Improve Jobsite Visibility and Subcontractor Accountability
  • Everything Policy Unveils Their Classroom Resources Behind Every Policy Topic
  • Roots for Boots to Participate in 2026 Adams County Community Foundation Giving Spree
Accelerated Treatment Systems
SHERMAN OAKS, Calif. - PennZone -- Gary S. Monroe, C.D. (Clinical Director) for Accelerated Treatment Systems, in Sherman Oaks, California, recently met with Mike Pavlovich, PharmD, FAPhA, of Westcliff Compounding Pharmacy, in Newport Beach, California, to discuss several promising treatments for Cocaine and Methamphetamine addicts.

The discussion centered around several medications (GABAergic medications, such as baclofen, tiagabine, and topiramate, and the glutamatergic medication, modafinil.  Disulfiram, an old treatment for alcohol dependence, may also have efficacy for cocaine relapse prevention.) that block cocaine euphoria, or reduce cocaine craving and have shown potential to reduce the chances of relapse. Two studies regarding Methamphetamine addiction have shown promising results with the use of Naltrexone, Bupropion, and A118G Polymorphism.

Accelerated Treatment Systems plans on conducting several studies of their own with these treatments.  "We plan to get moving quickly, to bring hope to individuals who suffer from this debilitating issue and bring in the appropriate investment and scientific research," said Mr. Gary S. Monroe.

More on The PennZone
  • Stand Strong Fencing of Hatfield Turns Every October Project Into a Cancer Donation
  • New Children's Picture Book "Tippy Tay" Explores the Dangers of Peer Pressure and the Importance of
  • Former Goddard Enterprises Managing Director Anthony Ali Joins STS Capital Partners as Managing Director and Partner
  • Heritage at Manalapan Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Homes
  • Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event

About Gary S. Monroe
Gary S. Monroe is an Entrepreneur, an Entertainment Industry veteran, and the Founder of Accelerated Treatment Systems in Sherman Oaks, California, where he serves as Clinical Director.  He has been in recovery for 29 years.

https://www.linkedin.com/in/gary-monroe-lion-62449287

About Mike Pavlovich
Mike Pavlovich, PharmD, FAPhA is a Pharmacist and the President of Westcliff Compounding Pharmacy, a multi-disciplinary pharmaco-medical practice specializing in pain management and pharmaceutical compounding based in Newport Beach, California. Mr. Pavlovich served as a Trustee for the American Pharmacists Association from 2008-2014 and is a graduate of the University of the Pacific.

https://www.westcliffcompounding.com/index.html

About Accelerated Treatment Systems
Accelerated Treatment Systems is a Sherman Oaks, California, based Addiction treatment facility founded by Gary S. Monroe, C.D.

https://acceleratedtreatmentsystems.com/

Contact
Justin Waters
***@tonupinc.com


Source: Accelerated Treatment Systems

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Detroit Lawyer Steals $600,000 Settlement Meant to Protect Child
  • The Great Junk Hunt Makes Its Highly Anticipated Stop in Philadelphia (Oaks)!
  • Heritage at South Brunswick Announces Special Townhome Mortgage Rate Buydown
  • Heritage at Hopewell Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Townhomes
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton
  • Ashley Russo Receives Linny Lifetime Achievement Award
  • How to Choose a Heating Repair Company in Philadelphia
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
  • Lehigh County Drug and Alcohol Celebrates Grand Opening of Journeys
  • Timbrana Addresses the Missing Follow-Through in Commercial Construction Projects
  • AI Agents Are Getting Their Own Computers. HRTech Leading in Vertical Harness Development
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
  • JKS Financial Gives Back Through Light of Life Rescue Mission Food Pantry
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Corner Property Management AAMC Expands Presence with Clover Mill Management Agreement
  • Michael Fischer Launches 'Legacy League' Podcast
  • Keystone Consulting Engineers Marks Next Chapter of Growth with Refreshed Brand
  • AutoProIT Achieves Cyber Essentials Certification, Reinforcing Its Commitment to Secure Digital Transformation
  • DayPass llega a ChatGPT y Claude
  • DayPass launches in ChatGPT and Claude

Popular on PennZone

  • Dion Abadi Publishes Free Collector Tips Hub for Art and Jewelry Buyers - 143
  • UVIFY Brings Advanced Autonomous Systems Research to IROS 2026 in Pittsburgh - 107
  • Subject matter experts: Present your ideas at IISE Annual Conference 2027 in Louisville
  • New Metallized PE Film from Pregis Brings Recyclability to High-Barrier Food Packaging at Pack Expo International in Chicago
  • Curtis Salgado shares a love letter to the city of Chicago and Otis Rush with new single
  • SMACK Fighting Championships Announces Influencer Fight Night at Harrah's Philadelphia
  • World-Renowned Body Language Expert Mark Bowden Headlines INSPIRE Northwest 2026 in Wenatchee, WA
  • Keystone Consulting Engineers Expands into Brodheadsville, Strengthening Regional Engineering
  • Revenue Optics Names Prat Patibandla Director of Growth Marketing
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026

Similar on PennZone

  • Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Acuvance Survey Finds ERP Integration Remains a Key Challenge as Healthcare Organizations Prepare for AI
  • HSS Medical Supply Celebrates One-Year Anniversary of Its Top Performing Sales Team
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Massage Revolution Expands to Santa Monica With New Wilshire Boulevard Location
  • Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us